Touchlight Genetics Ltd
Morelands & Riverdale Buildings
Lower Sunbury Road
Hampton
TW12 2ER
United Kingdom
Tel: 44-0-20-8481-9200
Fax: 44-0-20-8481-9210
Website: http://www.touchlight.com/
About Touchlight Genetics Ltd
Touchlight was established on the conviction that our ever increasing understanding of DNA would lead to its emergence as a material of the future.As such we have developed, patented, scaled and evidenced a revolutionary platform to enable the next generation of DNA industries.
YEAR FOUNDED:
2008
LEADERSHIP:
CEO: Johnny Ohlson
7 articles about Touchlight Genetics Ltd
-
Touchlight Completes Expansion, Creating One of the World’s Largest DNA Manufacturing Facilities in London, UK
5/24/2023
Facility will have capacity that exceeds global plasmid DNA demand and can enable commercialisation of genetic medicines.
-
Touchlight Announces First FDA Clearance of an IND Utilising Doggybone DNA
2/28/2023
Touchlight, a CDMO pioneering enzymatic DNA production to enable genetic medicines, today announced the first FDA clearance of an Investigational New Drug (IND) application in the US utilising doggybone DNA (dbDNA™).
-
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight’s Enzymatic doggybone DNA Technology
1/24/2023
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a ground-breaking new milestone for its enzymatic doggybone DNA (dbDNA™), following the FDA acceptance of the Drug Master File (DMF) for GMP grade dbDNA.
-
Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement to Develop Personalised Cancer Therapy Utilising Doggybone DNA
12/7/2022
Touchlight announces a development and supply agreement with Odimma Therapeutics, a French biotech company focusing on personalised cancer immunotherapy.
-
AskBio and Touchlight Restructure Joint Venture
2/8/2022
Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, and Touchlight, a biotechnology company pioneering enzymatic DNA production, have announced a revised structure to their former joint venture, Touchlight AAV.
-
Touchlight and Vanderbilt University Medical Center collaborate on DARPA Pandemic Prevention Platform programme to develop synthetic DNA-based antibody to protect against emerging threats
7/28/2021
Touchlight, the leading synthetic DNA manufacturer, is collaborating with the Vanderbilt Vaccine Center at Vanderbilt University Medical Center as part of the DARPA P3 programme.
-
Touchlight Genetics Announced As Best Emerging UK Synthetic Biotech Company At OBN Awards 2016
10/7/2016